| GeneLibs

题目:: The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.
作者:: Fournier(Pierrick G J),Juárez(Patricia),Jiang(Guanglong),Clines(Gregory A),Niewolna(Maria),Kim(Hun Soo),Walton(Holly W),Peng(Xiang Hong),Liu(Yunlong),Mohammad(Khalid S),Wells(Clark D),Chirgwin(John M),Guise(Theresa A)
状态:: 发布时间2015-06-10 , 更新时间 2016-10-19
期刊:: Cancer Cell
摘要:: Transforming growth factor-β (TGF-β) regulates the expression of genes supporting breast cancer cells in bone, but little is known about prostate cancer bone metastases and TGF-β. Our study reveals that the TGFBR1 inhibitor SD208 effectively reduces prostate cancer bone metastases. TGF-β upregulates in prostate cancer cells a set of genes associated with cancer aggressiveness and bone metastases, and the most upregulated gene was PMEPA1. In patients, PMEPA1 expression decreased in metastatic prostate cancer and low Pmepa1 correlated with decreased metastasis-free survival. Only membrane-anchored isoforms of PMEPA1 interacted with R-SMADs and ubiquitin ligases, blocking TGF-β signaling independently of the proteasome. Interrupting this negative feedback loop by PMEPA1 knockdown increased prometastatic gene expression and bone metastases in a mouse prostate cancer model.
语言:: eng
DOI:

文献库文献相关信息